drug · small molecule
azetukalner
Phase 3updated 5mo agoby $XENE Xenon Pharmaceuticals Inc.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 6 investigational indications.
indications
indications
Major Depression
all catalysts(0)
nothing on the calendar yet
Trials studying azetukalner
- phase3A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- phase3An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
- phase3An Open-Label Study of Azetukalner in Major Depressive Disorder
- phase3A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- phase3A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
News(4)
- Xenon shares fall following depression trial pauseThe occurrence of “neuropsychiatric” adverse events in testing fueled investor doubts about a drug the FDA is already reviewing for a form of epilepsy.biopharma_dive · 12d ago
- Xenon tumbles on voluntary psychiatry hold, but analysts confident in $2B epilepsy opportunityAs Xenon Pharmaceuticals announced that azetukalner has reached the FDA for focal seizures, the company also disclosed the emergence of psychosis adverse events in psychiatric trials of the drug, t…biospace · 12d ago
- Xenon pauses phase 3 depression trials after psychosis eventsThe company has voluntarily stopped enrolling new patients in the studies in response to reports of mostly mild or moderate adverse events.fiercebiotech · 12d ago
- SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launchSK Biopharmaceuticals has strengthened its epilepsy offering by paying $350 million upfront to help speed Biohaven’s Kv7 ion channel activator on its way to market.fiercebiotech · 1mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that